Intellia Therapeutics, Inc. · NASDAQ:NTLA

Verwiel Frank received 9,200 Intellia Therapeutics, Inc. shares as an award (Form 4)

Traded Jun 9, 2026 · Filed Jun 10, 2026

On Jun 9, 2026, Verwiel Frank (Director) received 9,200 Intellia Therapeutics, Inc. shares as an award, leaving 35,148 shares. Filed Jun 10, 2026 (Form 4).

Awarded
9,200 shares
Holding after
35,148 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 9, 2026Common StockAward9,20035,148Direct

Source

View original at SEC

Related